Search

Author/Creator Kerkmann, Urs

1. Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial. Issue 10348 (23rd July 2022)

Authors:
Reich, Kristian; Thyssen, Jacob P; Blauvelt, Andrew; Eyerich, Kilian; Soong, Weily; Rice, Zakiya P; Hong, H Chih-ho; Katoh, Norito; Valenzuela, Fernando; DiBonaventura, Marco; Bratt, Tamara A; Zhang, Fan; Clibborn, Claire; Rojo, Ricardo; Valdez, Hernan; Kerkmann, Urs
Journal:
Lancet
Issue:
Volume 400:Issue 10348(2022)
Page Start:
273
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Rapid Improvement of Itch Associated With Atopic Dermatitis With Abrocitinib Is Partially Independent of Overall Disease Improvement: Results From Pooled Phase 2b and 3 Monotherapy Studies. Issue 1 (7th October 2021)

Authors:
Kim, Brian S.; Silverberg, Jonathan I.; Ständer, Sonja; Yosipovitch, Gil; Simpson, Eric L.; DiBonaventura, Marco; Kerkmann, Urs; Farooqui, Saleem A.; Biswas, Pinaki; Valdez, Hernan; Cameron, Michael C.
Journal:
Dermatitis
Issue:
Volume 32:Issue 1S(2021)
Page Start:
S39
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Rapid Improvement of Itch Associated With Atopic Dermatitis With Abrocitinib Is Partially Independent of Overall Disease Improvement: Results From Pooled Phase 2b and 3 Monotherapy Studies. Issue 1 (October 2021)

Authors:
Kim, Brian S.; Silverberg, Jonathan I.; Ständer, Sonja; Yosipovitch, Gil; Simpson, Eric L.; DiBonaventura, Marco; Kerkmann, Urs; Farooqui, Saleem A.; Biswas, Pinaki; Valdez, Hernan; Cameron, Michael C.
Journal:
Dermatitis
Issue:
Volume 32:Issue 1S(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search